相关实验视频
Updated: Jul 5, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.2K
过敏性喘的过敏原免疫疗法
J Christian Virchow1, Oliver Pfaar2, Marek Lommatzsch1
1Department of Pneumology, Rostock University Medical Centre, University of Rostock, Rostock, and.
Allergologie select
|January 22, 2024
概括
过敏原免疫疗法 (AIT),包括皮下 (SCIT) 和舌下 (SLIT) 形式,可以预防过敏性鼻炎患者的喘,并有助于实现过敏性喘患者的缓解. 精确的患者表型是成功AIT结果的关键.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 呼吸系统医学 呼吸系统医学
- 个性化医疗是个性化的医疗.
背景情况:
- 喘缓解是当代喘管理的主要目标.
- 过敏原免疫疗法 (AIT) 是对过敏状况的关键个性化治疗方法.
- 通过皮下 (SCIT) 或舌下 (SLIT) 途径传递的AIT发挥着重要作用.
研究的目的:
- 突出AIT在喘预防和缓解中的作用.
- 强调在过敏性鼻炎和过敏性喘患者中AIT的重要性.
- 强调为有效的AIT需要精确的患者表型.
主要方法:
- 关于喘过敏原免疫治疗的当前文献的综述.
- 分析AIT在预防过敏性鼻炎中喘发展的疗效.
- 评估AIT在被诊断为喘患者中实现喘缓解的潜力.
主要成果:
- AIT (SCIT/SLIT) 可以降低患有过敏性鼻炎的人患喘的风险.
- AIT提供了一种可行的策略,可以在患有过敏性喘的患者中实现缓解.
- 成功的AIT结果取决于准确的患者表型.
结论:
- 对于有记录过敏的喘患者,应强烈考虑过敏原免疫治疗.
- 通过AIT进行个性化喘治疗,需要详细的患者表型,以获得最佳结果.
- AIT代表了预防和管理喘的有价值的治疗选择.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
299
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299
Allergic Reactions
27.4K
Overview
27.4K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
405
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
405
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K

